For information about COVID-19, including symptoms and prevention, please read our COVID-19 patient guide. Please also consider supporting Weill Cornell Medicine’s efforts against the pandemic.
Jill Roberts Center for Inflammatory Bowel Disease
The Jill Roberts Center for Inflammatory Bowel Disease provides personalized treatment to patients with inflammatory bowel disease (IBD) and collaborates with investigators from the Jill Roberts Institute on research in Crohn’s disease and ulcerative colitis. The center offers a comprehensive and personalized approach to patient care, which includes a dedicated IBD nutrition program, stress management support and IBD genetic testing and counseling. Patients have access to the latest developments in IBD treatments and the opportunity to participate in a wide array of clinical trials, intended to help them reach and maintain a long-term state of remission.
News
Fungus in Gut May Explain Why Some Ulcerative Colitis Patients Benefit from Fecal Transplant
May 14, 2020
Higher levels of a type of fungus in the gut are associated with better outcomes for patients with a type of inflammatory bowel disease called ulcerative colitis who are treated...
Scientists Identify New Pathways to Inflammation in Allergy-Linked Immune Cells
April 30, 2020
A class of immune cells push themselves into an inflammatory state by producing large quantities of a serotonin-making enzyme, according to a study in mice led by scientists at...
Dr. Randy Longman Appointed Director of the Jill Roberts Center for Inflammatory Bowel Disease
October 29, 2019
Dr. Randy Longman, an accomplished physician-scientist, has been appointed director of the Jill Roberts Center for Inflammatory Bowel Disease at Weill Cornell Medicine and NewYork...